DIA Biosimilars 2013

Leukemia & Lymphoma Society

LLS, Valor Biotherapeutics partner to advance novel therapy

Thursday, May 30, 2013 04:18 PM

The Leukemia & Lymphoma Society (LLS), a global voluntary health agency,  is committing approximately $6 million to Valor Biotherapeutics, a joint venture of biotechnology companies ImmunGene and Caliber, to co-fund the completion of preclinical development, manufacturing and a phase I clinical trial for a novel fusion protein that may change the poor outcomes faced by many patients with indolent lymphomas who do not respond to standard therapy with rituximab.

More... »

Cenduit: Now with Patient Reminders

Leukemia & Lymphoma Society expands chief policy, advocacy officer role

Friday, March 8, 2013 10:34 AM

The Leukemia & Lymphoma Society (LLS) has expanded the role of chief policy and advocacy officer Mark Velleca, M.D., Ph.D. Velleca, who has headed LLS' Office of Public Policy in Washington, D.C., since early 2012, will now oversee the newly integrated patient advocacy, policy and programs department.

More... »

CRF Health – eCOA Forum

Constellation, LLS to develop novel BET inhibitor for hematologic malignancies

Friday, September 21, 2012 01:12 PM

Constellation Pharmaceuticals, a Cambridge, Mass.-based biopharmaceutical company in the field of epigenetics, has entered into a strategic partnership with the Leukemia & Lymphoma Society (LLS) to advance the development of a novel BET inhibitor for the treatment of patients with hematologic malignancies.

More... »

Leukemia & Lymphoma Society awards $12M in grants for blood cancer

Thursday, August 30, 2012 11:54 AM

The Leukemia & Lymphoma Society (LLS) of White Plains, N.Y., has awarded 20 grants representing a total investment of $12 million to tackle four areas of high unmet medical need in the blood cancers.

More... »

CenterWatch Drugs in Clinical Trials Database Library. Drug intelligence right at your fingertips.
CLINICAL TRIAL RESOURCES

Search:

NEWS ONLINE ARCHIVE

Browse by:

CWWeekly

September 30

Novartis-Walgreens pilot study blurring the line between retail pharmacy, investigative site

CISCRP to launch traveling science museum exhibit to demystify clinical trial participation

Already a subscriber?
Log in to your digital subscription.

Subscribe to CWWeekly.

The CenterWatch Monthly

October

New growth and decline in Asia clinical trials
South Korea, Japan, China see big growth in 1572s, while India posts huge drop

Harnessing Big Data to transform clinical trials
From protocol to patient recruiting, data analytics can yield valuable insights

Already a subscriber?
Log in to your digital subscription.

Purchase the October issue.

Subscribe to
The CenterWatch Monthly.

The CenterWatch Monthly

September

Sponsors look to collaborate on comparator drugs
Co-therapies, comparators are in 60% of studies, cost $25m per company a year

Early adopters implement risk-based monitoring pilot programs
Experiments aim to offer long-term solutions, despite short-term uncertainties

Already a subscriber?
Log in to your digital subscription.

Purchase the September issue.

Subscribe to
The CenterWatch Monthly.

JobWatch centerwatch.com/jobwatch

Featured Jobs